Nerve growth peptides
US5545719A · kind A · utility
37Cited by
12References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 24, 1994 |
| Grant date | Aug 13, 1996 |
| Priority date | — |
| Expiry date | Feb 24, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention describes novel molecules capable of promoting nerve growth, and therapeutic methods for promoting nerve growth using these molecules. Molecules of this invention include a protein fragment substantially homologous to an active region of the brain glycoprotein ependymin. The active region is primarily responsible to the nerve growth promoting capacity of these molecules. The molecules of this invention may be administered to a subject to correct genetic and systemic disorders and to treat nervous systems disorders resulting from trauma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.